Welcome to our dedicated page for National Healthcare Properties SEC filings (Ticker: NHPAP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for National Healthcare Properties, Inc. 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (Nasdaq: NHPAP) provides access to the issuer’s regulatory documents filed with the U.S. Securities and Exchange Commission. NHPAP is a series of cumulative redeemable perpetual preferred stock issued by National Healthcare Properties, Inc., a self-managed healthcare real estate investment trust that focuses on seniors housing and outpatient medical facilities.
Through this page, users can review the company’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe the performance of the seniors housing operating property (SHOP) and outpatient medical facility (OMF) segments, discuss risk factors and outline the REIT’s use of non-GAAP measures such as Funds from Operations (FFO), Adjusted Funds from Operations (AFFO), Adjusted EBITDA, NOI and Cash NOI. These filings help investors understand the operating results and cash flow metrics that support dividends on securities like NHPAP.
The page also includes current reports on Form 8-K, where National Healthcare Properties discloses material events such as new or amended credit facilities, changes in executive leadership, board and governance actions, amendments to rights agreements and other significant developments. For example, 8-K filings describe the company’s senior unsecured credit facility, employment agreements with key executives, board declassification and bylaw amendments, and changes to rights associated with its common stock.
In addition, investors can access filings related to preferred stock dividends, capital structure changes and other matters affecting the rights of preferred holders. Stock Titan’s platform pairs these filings with AI-powered summaries that explain key terms, highlight important covenants and governance changes and clarify how reported metrics like Net Debt and Net Debt to Annualized Adjusted EBITDA relate to the company’s leverage.
By using this SEC filings page, users can quickly locate and interpret the official documents that define National Healthcare Properties’ financial reporting, capital structure and governance framework as they relate to NHPAP and the broader REIT.
National Healthcare Properties, Inc. amended the executive employment agreement with its Chief Executive Officer and President, Michael Anderson. The amendment extends the agreement’s term from September 27, 2027 to September 27, 2030. After that date, the agreement will automatically renew for additional one-year periods unless either party gives written notice at least 90 days before the applicable term date. All other provisions, including compensatory terms, remain unchanged from those described in the company’s March 31, 2026 proxy statement.
National Healthcare Properties, Inc. Schedule 13G/A: Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report potential beneficial ownership of 614,913 shares of Class A Common Stock, representing 1.4% of the class.
The filing states the shares are held by entities over which Millennium Management LLC and/or other managers controlled by Millennium Group Management LLC and Mr. Englander have voting and investment discretion. The joint filing agreement is dated July 8, 2026.
National Healthcare Properties, Inc. ownership disclosure: Prudential Financial, Inc. reports beneficial ownership of 4,504,336 shares of Common stock, representing 10.2% of the class. The filing states shared voting and dispositive power over those 4,504,336 shares, held indirectly through subsidiaries including PGIM, Inc. and PGIM Quantitative Solutions LLC.
National Healthcare Properties, Inc. (NHP) disclosed that MacKenzie Capital Management launched an unsolicited mini-tender offer to buy up to 150,000 common shares, about 0.2% of outstanding stock, at $7.27 per share. This price is approximately 47.2% below the $13.78 last reported sale price of NHP’s Class A common stock on Nasdaq as of June 15, 2026.
After consulting outside advisors, NHP’s board decided not to make a recommendation and to remain neutral on whether stockholders should tender. The company’s letter notes that tendering holders would give up rights to future distributions after March 31, 2026 and that the MacKenzie offer price will be reduced by any cash distributions made after that date. It also highlights that NHP insiders do not intend to tender and references SEC cautions about mini-tender offers.
Principal Global Investors, Principal Real Estate Investors LLC and Principal Funds, Inc. jointly report beneficial ownership of 5,088,743 shares of Class A common stock of National Healthcare Properties, Inc., representing 11.5% of the class as of 05/31/2026.
The filing shows shared voting and dispositive power held across the filers: Principal Real Estate Investors LLC holds 4,981,351 shares (11.3%) and Principal Funds, Inc. holds 2,776,639 shares (6.3%). The statement is signed and dated 06/01/2026.
Humphrey Scott reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Properties, Inc. director Humphrey Scott received a grant of 9,935 LTIP Units on May 15, 2026 as compensation. These LTIP Units are convertible into 9,935 OP Units and ultimately redeemable for either cash or an equal number of common shares. Following this award, Scott holds 22,435 LTIP Units in total. The LTIP Units will vest on May 15, 2027, conditioned on continued service, and do not have expiration dates.
Weil Edward M Jr. reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Properties, Inc. director Edward M. Weil Jr. received a grant of 7,446 LTIP Units as equity-based compensation. The LTIP Units are convertible into an equivalent number of operating partnership units, which can be redeemed for cash or, at the company’s election, shares of common stock on a one-for-one basis.
The LTIP Units vest on May 15, 2027, subject to his continued service through that date. After this grant, he holds 19,946 LTIP Units and 3,110 shares of common stock directly.
Penn Buddie J reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Properties, Inc. director Buddie J. Penn received a grant of 7,446 LTIP Units on May 15, 2026 as equity compensation. These LTIP Units will vest on May 15, 2027, subject to continued service, and are ultimately redeemable for cash or, at the issuer’s election, an equal number of common shares. After this grant, Penn holds 19,946 LTIP Units and 7,697 shares of common stock directly.
National Healthcare Properties, Inc. launched concurrent cash tender offers of up to $100 million in aggregate to repurchase its 7.375% Series A and 7.125% Series B cumulative redeemable perpetual preferred stock.
Both series are offered at $22.50 per share, less any applicable withholding taxes and without interest. The offers commence on May 18, 2026 and are intended to expire at 5:00 p.m. New York City time on June 16, 2026, unless extended or terminated. The company plans to fund the repurchases with available cash.
Series A shares have higher purchase priority than Series B, and within each offer, holders of fewer than 100 shares who tender all their holdings receive “odd lot” priority. If tenders exceed the $100 million cap, Series B tenders may be prorated. The offers are not contingent on financing or any minimum number of shares, but remain subject to other conditions detailed in a forthcoming Offer to Purchase and related Schedule TO materials.
National Healthcare Properties, Inc. entered into a definitive purchase and sale agreement to sell a portfolio of 86 outpatient medical facilities for approximately $528 million, including about $278 million of secured debt to be defeased or assumed by the purchaser.
The agreement with an unaffiliated third party includes customary representations, covenants and post-closing obligations. The transaction is expected to close in the third or fourth quarter of 2026, subject to the purchaser’s due diligence, lender approval of loan assumptions and other customary closing conditions. This Form 8‑K/A amends the prior report solely to correct a typographical error.